Gene Query: ATP8A1

Dataset Description Geneva Score
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 67.26
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 67.26
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 59.76
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 59.76
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 58.94
Dtx3L and Androgen Signaling in Prostate Cancer 57.68
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 56.23
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 44.77
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 42.48
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 42.18
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 38.94
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 38.94
Global gene expression profile of dasatinib-resistant RCH-ACV cells 38.16
Global transcriptome analysis of HAP1 cells 38.01
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 37.5
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 37.5
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 34.54
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 34.07
FOXP2's impact on the primate transcriptome 32.91
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 31.04
The pause-initiation limit restricts transcription activation in human cells 30.42
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 29.65
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 29.65
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 29.43
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 29.12
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 28.74
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 27.82
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 25.12
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 25.09
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 24.86
Depicting early human development and germ cell origin with porcine embryos 24.38
The comparison of high-throughput single-cell RNA-seq methods 23.95
RNAseq Study in CC-671 Treated Cal-51 Cells 23.7
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 23.55
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 23.1
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 21.99
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 21.57
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 21.18
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 21.08
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 20.11
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 19.7
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 19.24
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 18.81
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 18.81
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 18.61
RNA sequencing of primary human platelets and in vitro cell lines 18.56
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 18.45
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 18.41
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 18.16
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 18.16
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 18.1
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 17.86
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 17.86
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 17.64
Transcriptome analysis of human lung epithelial cells 17.49
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 17.39
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 17.38
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 17.38
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 17.24
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 17.15
SETBP1-WT and SETBP1-G870S epigenetic landscapes 17.11
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 17.11
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 17.03
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 16.95
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 16.7
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 16.7
Expression profiles of the four human major ectodermal lineages 16.69
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 16.61
BET bromodomain inhibition 16.57
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 16.57
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 16.48
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 16.4
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 16.4
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 16.02
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 16.02
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 15.93
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 15.65
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 15.63
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 15.54
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 15.48
RNA-seq of resting and activated CD4+ T cells +-JQ1 15.35
Transcriptome of Stabilin-1 siRNA transfected human monocytes 15.21
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 15.09
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 15.09
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 15.09
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 14.99
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 14.99
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 14.98
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 14.95
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 14.93
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 14.92
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 14.92
RNA expression following TMPRSS11B overexpression or depletion 14.62
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 14.54
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 14.43
circRNA-sequencing 14.3
Identification of global regulators of T-helper cell lineage specification 14.23
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 14.23
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 14.23
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 14.22
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 14.22
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 13.82
Impact of dieldrin on transcription in Jurkat T cells 13.79
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 13.78
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 13.78
Transcriptome analyses of human pancreatic islets and pseudoislets 13.71
MeRIP-seq for heat shock in B-cell lymphoma cells 13.7
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 13.61
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 13.61
Transciptomic profiling of human fetal lung samples 13.59
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 13.57
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 13.56
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 13.55
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 13.28
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 13.28
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 13.23
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 13.03
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 12.98
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 12.82
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 12.82
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 12.81
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 12.66
Transcriptome of human white and brown adipose tissue biopsies 12.61
Genome-wide functional assessment of enhancer activities in the human genome 12.58
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 12.57
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.52
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 12.42
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 12.39
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 12.38
The contribution of Alu exons to the human proteome 12.26
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 12.04
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 11.85
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 11.84
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 11.7
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 11.69
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 11.5
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 11.5
BI Human Reference Epigenome Mapping Project 11.45
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 11.41
The cohesin release factor WAPL restricts chromatin loop extension. 11.38
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 11.38
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 11.35
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 11.29
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 11.29
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 11.27
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 11.19
Short and Long RNA sequencing of human mature erythrocytes 10.93
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 10.91
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 10.91
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 10.85
Examining serotonergic neuron differentiation from human iPSCs 10.79
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 10.77
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 10.75
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 10.75
The effect of Abl kinases on non-small cell carcinoma global transcriptome 10.74
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 10.71
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 10.71
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 10.6
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 10.56
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 10.56
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 10.56
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 10.56
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 10.52
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 10.52
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 10.47
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 10.44
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 10.36
RNA sequencing of matched nephrectomy samples [RNA-seq] 10.34
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 10.34
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 10.3
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 10.24
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 10.1
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 10.07
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 10.03
RNA sequencing with KSHV infection and enrichment for circular RNAs 9.9
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 9.77
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 9.69
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 9.56
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 9.52
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 9.5
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 9.49
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 9.47
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 9.46
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 9.42
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 9.37
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 9.32
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 9.31
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 9.3
Widespread intronic polyadenylation diversifies immune cell transcriptomes 9.25
Integrin signaling regulates YAP/TAZ to control skin homeostasis 9.17
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 9.16
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 9.08
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 9.03
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 8.97
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 8.97
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 8.92
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 8.9
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 8.89
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 8.87
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 8.86
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 8.82
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 8.74
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 8.71
HNRNPM-regulated splicing dependencies in prostate cancer 8.71
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 8.71
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 8.7
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 8.65
Gene expression profile of multiple myeloma cell lines treated with CB-5083 8.63
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 8.59
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 8.59
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 8.59
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 8.58
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 8.58
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 8.52
Multiple sclerosis and EAE 8.51
Human optic chiasm from healthy controls and multiple sclerosis patients 8.51
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 8.33
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 8.31
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 8.23
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 8.19
RNA sequencing of BT142 and TS603 cell lines 8.18
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 8.18
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 8.16
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 8.11
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 8.11
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 8.11
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 8.03
MYCi975 regulates MYC target genes 8.0
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 7.97
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 7.87
Reprogrammed myeloid cell transcriptomes in NSCLC 7.81
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 7.8
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 7.79
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 7.73
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 7.72
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 7.7
The Glioma-Infiltrating T Cell Receptor Repertoire 7.67
HNF1A deficiency impairs β-cell fate, granule maturation and function 7.65
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 7.64
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 7.64
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 7.62
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 7.61
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 7.59
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 7.55
Patient-derived luminal breast cancer xenografts with progestins 7.55
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 7.55
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 7.54
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 7.5
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 7.43
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 7.42
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.39
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 7.3
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 7.28
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 7.19
Alteration of the microRNA network during the progression of Alzheimer’s disease 7.18
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 7.13
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 7.11
Downregulation of DDX5/DDX17 and REST 7.03
CircRNAome diversity in human mature B-cells, T-cells and monocytes 6.94
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 6.9
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 6.9
Primary Human B-cell Temporal Response to CD40L Stimulation 6.87
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 6.86
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 6.86
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 6.84
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 6.83
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 6.73
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 6.67
Global analysis of alternative splicing regulated by RBM10 6.65
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 6.65
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 6.64
Expression and functions of long noncoding RNAs during human T helper cell differentiation 6.59
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 6.54
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 6.39
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 6.37
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 6.36
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.28
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 6.24
Measure transcript integrity using RNA-seq data 6.2
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 6.19
Effect of PRDM11 depletion in U2932 cells 6.19
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 6.11
Gene expression profiling of papillary thyroid cancer from central and invasive regions 6.08
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 6.08
Effect of Hotair overexpression in human breast cancer cell lines 6.05
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 6.03
Global response to chemotherapy-induced apoptosis 6.02
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 5.93
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 5.91
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 5.91
FGF2 regulation of gene expression in stable inducible Neurons 5.91
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.9
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 5.81
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 5.78
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 5.75
Hepatosplenic T cell lymphoma 5.75
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 5.73
A practical evaluation of alignment algorithms for RNA variant calling analysis 5.71
Global transcriptome analysis of WT versus HEB-/- hESCs 5.68
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 5.67
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.58
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 5.56
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.54
Molecular analysis of renal cell carcinoma with unclassfied histology 5.5
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 5.5
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 5.46
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 5.42
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 5.32
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 5.32
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 5.26
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 5.26
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 5.24
Repurposing of promoters and enhancers during mammalian evolution 5.23
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.22
Gene expression signatures of innate lymphoid cells from human blood 5.14
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 5.13
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 5.1
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 5.04
RNA-Seq from human ILC transitional populations 5.04
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 4.99
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 4.99
Seletive inhibition of CDK9 in DLBCL cell lines 4.95
Universal alternative splicing of noncoding exons 4.93
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 4.93
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 4.87
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 4.84
Disruption of GRIN2B impairs differentiation in human neurons 4.82
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.77
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 4.76
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 4.73
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 4.73
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 4.69
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 4.69
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.68
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.68
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 4.65
RNA-sequencing of healthy human skeletal myocytes 4.65
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.65
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.64
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 4.59
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 4.59
Engineering Patient-Specific Tissue Implants 4.57
Common inflammatory pathways between NEC and Crohn's disease 4.55
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.51
JAK dependent survival of ALK- ALCL 4.48
Gene expression profiling in metabolically heterogeneous human lung tumors 4.44
Transcriptome analysis reveals differential splicing events in IPF lung tissue 4.32
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.3
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 4.2
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 4.16
RNAseq of T-ALL upon long non coding rna purturbation 4.08
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 4.01
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.91
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 3.9
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 3.9
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 3.79
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 3.61
Gene expression profiling of leukemia cells following asparagine depletion 3.52
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 3.42
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 3.42
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 3.39
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.38
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 3.37
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 3.36
Primate transcript and protein expression levels evolve under compensatory selection pressures 3.32
Characterization of the Merkel cell carcinoma miRNome 3.32
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 3.28
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.25
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 3.23
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 3.23
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 3.2
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 3.2
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.14
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 3.14
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 3.14
Leucegene: ALL sequencing 3.14
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 3.1
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 3.08
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 3.07
Transcriptome analysis upon C6orf203 silencing 3.06
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 3.06
RNA-sequencing 3.04
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.03
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 2.98
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 2.92
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.91
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.85
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 2.84
RNA-seq of primary patient AML samples 2.84
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.84
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 2.83
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.8
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 2.78
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.77
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 2.77
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 2.74
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 2.72
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 2.67
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 2.64
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.64
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.64
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.64
Total RNA-Seq data from leukemic patients with complex structural variants 2.62
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.52
naive T cell heterogeneity after neonatal thymectomy 2.49
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 2.44
Human islets of varying quality: the good, the (not so) bad and the ugly 2.36
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.25
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 2.25
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 2.25
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.2
Human ovarian granulosa cell transcriptome 2.16
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 2.16
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 2.16
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.11
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 2.04
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.02
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 1.98
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.96
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.93
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.88
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.87
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.86
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.86
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.85
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.83
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.78
Identification of expressed and conserved human non-coding RNAs 1.72
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.68
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.6
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.56
RNA-Seq in PWS iPSC-derived neurons 1.56
Preclinical model of obesity and ER-positive breast cancer 1.46
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.46
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.46
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.46
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 1.46
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.38
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.38
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.32
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.31
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.29
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.29
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.29
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.27
Transcriptomes in healthy and CHB fetal hearts 1.23
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 1.2
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 1.2
MAIT cell RNA sequencing 1.17
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.17
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 1.16
Leucegene: AML sequencing (part 6) 1.16
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.14
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 1.11
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.1
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.1
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.09
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.05
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 1.03
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 1.03
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.03
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.01
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.92
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.88
Aging-associated patterns in the expression of human endogenous retroviruses 0.75
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.72
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.61
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.59
RNA seq analysis of human Fetal and adult derived Enterospheres 0.57
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 0.56
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.56
Transcriptomic analysis of human macrophages in 3D 0.48
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.47
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.47
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 0.45
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 0.45
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.44
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.42
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.42
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.39
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.38
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.35
Identification of long noncoding RNAs in T-ALL cell lines 0.31
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.3
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.28
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.28
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.27
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.25
RNA-seq of SCLC PDX models treated with EP 0.24
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.22
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.18
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.18
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.18
Dilated cardiomyopathy vs Myocarditis 0.16
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 0.15
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.13
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.1
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.06
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.06
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation